Does Use of Rapid Response EEG Impact Clinical Decision Making
DECIDE
1 other identifier
observational
164
1 country
5
Brief Summary
This study is designed as a prospective, non-randomized, observational, multicenter clinical trial. The primary aim of this study is to observe if the use of the rapid responds electroencephalography (EEG) system impacts physician decision making. Secondary aims include exploring the safety and performance information of the Ceribell EEG system compared to conventional EEG system. The study will recruit physicians (Faculty physicians and Trainees) at up to five institutions and examine the impact of rapid response EEG when providing care to patients in whom EEG recording has been ordered for clinical reasons.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2018
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2018
CompletedStudy Start
First participant enrolled
April 30, 2018
CompletedFirst Posted
Study publicly available on registry
May 23, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedAugust 20, 2019
August 1, 2019
1 year
April 19, 2018
August 16, 2019
Conditions
Outcome Measures
Primary Outcomes (4)
Change in physicians' diagnosis decision
Physician will record their diagnostic assessment of seizure in Yes or No.
through study completion, an average of 1 year
Change in physicians' diagnosis confidence
Physician will rate their diagnosis confidence with a score between 1 to 5
through study completion, an average of 1 year
Change in physicians' treatment decision
Physician will record their treatment decision in Yes or No.
through study completion, an average of 1 year
Change in physicians' treatment confidence
Physician will rate their treatment confidence with a score between 1 to 5
through study completion, an average of 1 year
Secondary Outcomes (4)
Time from order to EEG arrival
through study completion, an average of 1 year
Set up time
through study completion, an average of 1 year
Ease of use
through study completion, an average of 1 year
Signal Quality of EEG
through study completion, an average of 1 year
Interventions
This trial will qualitatively examine how information from rapid response and conventional EEG data changes physicians' diagnostic suspicion or their treatment decisions and confidence levels. In addition, the results will examine the mean time to EEG lead placement, and ease of use.
Eligibility Criteria
The study will involve two groups of subjects: 1. Physicians (faculty and trainees), who will be asked to fill out a nonsensitive questionnaire. These are members of Epilepsy and Neuro-ICU team (attendings, fellows, or residents) who are actively involved in the care of patients and know the patient's history of present illness. 2. Patients undergoing clinically ordered EEGs.
You may qualify if:
- Patients undergoing clinically ordered EEGs.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ceribell Inc.lead
Study Sites (5)
University of California Los Angeles
Los Angeles, California, 90024, United States
Rush University Medical Center Pob
Chicago, Illinois, 60612, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27157, United States
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Related Publications (1)
Vespa PM, Olson DM, John S, Hobbs KS, Gururangan K, Nie K, Desai MJ, Markert M, Parvizi J, Bleck TP, Hirsch LJ, Westover MB. Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study. Crit Care Med. 2020 Sep;48(9):1249-1257. doi: 10.1097/CCM.0000000000004428.
PMID: 32618687DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2018
First Posted
May 23, 2018
Study Start
April 30, 2018
Primary Completion
April 30, 2019
Study Completion
July 31, 2019
Last Updated
August 20, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share